PATENT CLAIM ANALYSIS

Application Number: 16028024
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "480000"]

Abstract:
The present invention provides a novel method, composition, and kit for treating neuroblastoma by way of the use of a BTK inhibitor. Also provided is a method for identifying a BTK inhibitor.

Claim (Index 9):
A composition for treating neuroblastoma comprising an effective amount of a BTK inhibitor and a physiologically acceptable excipient.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14131183', '14597786', '15112968', '14117898', '15900201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7647477874090491
- 35 USC 102 Novelty (BERT): 0.5170821457490944
- Combined Prediction Score: 0.7399812232430537
- Mean Citation Score: 292.078884
- Max Citation Score: 301.78088
- Similarity Product: 202.6524345752049

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test